NCT01416441View on ClinicalTrials.gov

Safety and Tolerability Study of Once-weekly Oral Aripiprazole in Children and Adolescents With Tourette's Disorder

PHASE3CompletedINTERVENTIONAL
Enrollment

170

Participants

Timeline

Start Date

October 19, 2011

Primary Completion Date

March 13, 2014

Study Completion Date

March 13, 2014

Conditions
Tourette's Disorder
Interventions
DRUG

Aripiprazole

Aripiprazole tablets orally once daily.

Trial Locations (80)

100

Taipei

114

Taipei

1021

Budapest

1307

Dresden

1431

Sofia

4209

Kyiv

6725

Szeged

7004

Rousse

9010

Varna

10312

Staten Island

11000

Miguel Hidalgo

11030

Manhasset

19139

Philadelphia

21005

Vinnytsia

22903

Charlottesville

30308

Atlanta

30329

Atlanta

30625

Hanover

32610

Gainesville

32763

Orange City

33012

Hialeah

33126

Miami

33701

St. Petersburg

34000

Durango

36006

Poltava

36303

Dothan

37000

León

40447

Taichung

41915

Bucharest

44012

Avon Lake

44106

Cleveland

44130

Middleburg Heights

48302

Bloomfield Hills

50006

Changhua

52074

Aachen

54601

La Crosse

60612

Chicago

61068

Kharkiv

61153

Kharkiv

64710

Monterrey

66211

Overland Park

68131

Omaha

70114

New Orleans

72205

Little Rock

73112

Oklahoma City

73488

Stepanovka

75230

Dallas

78229

San Antonio

78258

San Antonio

80020

Culiacán

80336

München

83008

Donetsk

83301

Kaohsiung City

84106

Salt Lake City

89075

Ulm

90095

Los Angeles

91045

Luhansk

92108

San Diego

92595

Wildomar

92701

Santa Ana

94143

San Francisco

95815

Sacramento

98011

Bothell

200620

Craiova

400660

Cluj-Napoca

700265

Iași

46202-5200

Indianapolis

45229-3039

Cincinnati

T3B 6A8

Calgary

V1Y 1Z9

Kelowna

M5B 1T9

Toronto

M5T 2S8

Toronto

L1N 8M7

Whitby

420-767

Gyeonggi-do

626-770

Gyeongsang

400-711

Incheon

110-744

Seoul

138-736

Seoul

143-729

Seoul

03049

Kyiv

All Listed Sponsors
lead

Otsuka Pharmaceutical Development & Commercialization, Inc.

INDUSTRY

NCT01416441 - Safety and Tolerability Study of Once-weekly Oral Aripiprazole in Children and Adolescents With Tourette's Disorder | Biotech Hunter | Biotech Hunter